RICHARD ERIC DAVIS to Drug Synergism
This is a "connection" page, showing publications RICHARD ERIC DAVIS has written about Drug Synergism.
Connection Strength
0.042
-
Targeting the insulin-like growth factor-1 receptor to overcome bortezomib resistance in preclinical models of multiple myeloma. Blood. 2012 Oct 18; 120(16):3260-70.
Score: 0.021
-
The pan-deacetylase inhibitor panobinostat induces cell death and synergizes with everolimus in Hodgkin lymphoma cell lines. Blood. 2012 Apr 26; 119(17):4017-25.
Score: 0.021